1.
Rivera-Sánchez FE, Moreno-Licea C, Mellado-Orellana R, González-Santiesteban S, de la Peña-López R. Pneumonitis, a common adverse event of cyclin-dependent kinase 4/6 inhibitors: a case report. Int J Sci Rep [Internet]. 2022 Feb. 21 [cited 2025 Sep. 26];8(3):78-80. Available from: https://www.sci-rep.com/index.php/scirep/article/view/1030